Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is aortic stenosis a preventable disease?

Kwan-Leung Chan1

  • 1Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. kchan@ottawaheart.ca

Journal of the American College of Cardiology
|August 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic classification of isolated severe aortic regurgitation in a contemporary cohort of patients.

European heart journal open·2025
Same author

Echocardiography in Systemic Lupus Erythematosus.

Current cardiology reports·2024
Same author

Aortic Stenosis: Timing Is Everything.

JACC. Advances·2024
Same author

Sex Differences in the Arterial Hemodynamics of Patients With Degenerative Aortic Aneurysms.

The Canadian journal of cardiology·2023
Same author

Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry.

European heart journal·2023
Same author

Arterial Age and Early Vascular Aging, But Not Chronological Age, Are Associated With Faster Thoracic Aortic Aneurysm Growth.

Journal of the American Heart Association·2023
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Aortic stenosis (AS) progression involves lipoproteins, similar to atherosclerosis. Cholesterol-lowering studies are needed to prevent severe AS and its associated risks.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biochemistry

Background:

  • Aortic stenosis (AS) is the most common age-related valvular heart disease, leading to significant morbidity and mortality when severe.
  • Mild to moderate AS is generally well-tolerated, but progression to severe AS necessitates intervention.
  • The development of AS shares similarities with atherosclerosis, suggesting a complex, regulated process rather than simple degeneration.

Purpose of the Study:

  • To explore the role of lipoproteins in the pathogenesis of aortic stenosis.
  • To highlight the association between lipoproteins and AS progression based on existing evidence.
  • To advocate for prospective studies investigating cholesterol-lowering interventions for AS.

Main Methods:

  • Review of existing epidemiological and clinical studies on AS and lipoproteins.

Related Experiment Videos

  • Analysis of histological and immunochemical similarities between AS and atherosclerosis.
  • Identification of modifiable factors in AS development.

    • Main Results:

    • Lipoproteins are implicated as a key factor in the pathways crucial to AS development.
    • Strong epidemiological and clinical evidence supports the association between lipoproteins and AS.
    • AS progression mirrors sclerotic changes in the aortic valve, akin to atherosclerotic processes.

    Conclusions:

    • Aortic stenosis is a complex, regulated process involving modifiable factors like lipoproteins.
    • Further research, including prospective cholesterol-lowering trials, is warranted to manage AS progression.
    • Preventing or retarding AS progression could mitigate adverse cardiovascular events.